All Editorials articles – Page 3
-
CareersA more reasonable view of workplace adjustments
Normalising giving people what they need to do their jobs well
-
OpinionNursing success – what next for UK science?
Policy prescriptions for research need cross-party support
-
OpinionHolding the keys to a powerful future
Competition to build battery supply chains means supercharging support to attract investment
-
OpinionNuclear wasted
Atomic energy has the potential to reduce our carbon footprint, but the problem of waste is devilishly complex
-
-
OpinionN-heterocyclic carbenes are more than passive spectators
The practical importance of N-heterocyclic carbenes continues to grow
-
OpinionA year of war in Ukraine
The full-scale Russian invasion of Ukraine is now one year old. For Ukraine, the anniversary has been a moment to reaffirm support among its allies and keep the world’s attention on Kyiv as the conflict moves increasingly by increments with no end in sight. For the Kremlin, the moment has been used to justify continuing the war, as a special operation that was supposed to last weeks now runs into its second year. For those who have lived through the war, it’s a reminder of just how much has changed and how much has been lost.
-
CareersMore guidance makes job and university applications fairer
A question-based format helps candidates prioritise what to tell recruiters
-
OpinionA decade on Crispr is already poised to deliver on its promise
Gene editing could transform healthcare but no disease should be forgotten
-
OpinionHow long until papers list an AI as an author?
Artificial intelligence is superior to humans at numerous tasks, but it is still vulnerable to human biases
-
-
-
OpinionWill we always keep naming things after people?
Choosing a name deserves careful consideration
-
OpinionWe’re all in this together
As rivalry between countries increases scientific collaboration must be maintained to tackle our shared problems
-
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
-
OpinionThe incredible legacy of Tutankhamun
Three-thousand-year-old treasures can still enthral and inspire
-
CareersHighlighting different routes into science
Why we need a greater variety of educational paths
-
OpinionWhy glycans?
Glycoscience is turning out to be more interesting than anyone might have imagined
-
OpinionTrouble at the top of the UK government spells trouble for science too
Science craves certainty but the UK hasn’t been able to deliver it recently
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers